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ABSTRAK 
Kami telah menjalankan satu kajian ke atas kesan analog Prostaglandin PGF2o. terhadap 
tekanan intraokular mata pesakit yang menjalani pembedahan katarak. Sebanyak 72 mata 
pesakit yang menjalani pembedahan katarak menggunakan teknik endocapsular beserta 
implantasi kanta intra-okular menggunakan bahan viskoelastik, telah dibahagikan kepada 
dua kumpulan secara rawak. Sebanyak 36 mata pesakit di dalam kumpulan latanoprost 
menerima ubat titis latanoprost 0.005% sebaik selesai pembedahan sementara 36 mata 
pesakit di dalam kumpulan kontrol menerima ubat titis tetrahydrozoline hydrochloride 
(optizolin). Aspek-aspek lain rawatan dan pembedahan bagi kedua-dua kumpulan adalah 
sama. Tekanan intraokular telah diukur sebelum pembedahan (pra-pembedahan) dan 3, 6, 9 
dan 24 jam selepas pembedahan. 
Purata tekanan intraokular pra-pembedahan bagi kumpulan latanoprost adalah 12.31 ± 2.11 
mmHg dan bagi kumpulan kontrol adalah 12.72 ± 2.49 mmHg. Selepas pembedahan, 
tekanan intraokular sentiasa melebihi paras pra-pembedahan bagi kedua-dua kumpulan. 
Paras purata tekanan 1ntraokular meningkat 6 jam pertama selepas pembedahan (dari 17.75 
kepada 21.80 mmHg) dan kemudian menurun dengan paras terendah pada 24 jam selepas 
pembedahan. Corak perubahan tekanan yang sama ditunjukkan oleh kumpulan latanoprost 
(dari 15.94 kepada 19.11mmHg dalam masa 6 jam pertama), tetapi paras tekanan 
intraokular bagi ~umpulan latanoprost sentiasa lebih rendah dari kumpulan kontrol. 
Perbezaan purata tekanan intraokular dianta~a dua kumpulan ini bagaimanapun didapati 
tidak mempunyai perbezaan yang signifikan (J> > 0.05). 
ix 
Kesimpulannya, pengambilan ubat titis latanoprost 0.005% sebaik selesai pembedahan 
katarak tidak menghasilkan penurunan tekanan intraokular yang signifikan jika 
dibandingkan dengan kumpulan kontrol dalam masa 24 jam pertama selepas pembedahan. 
X 
ABSTRACT 
The effect of prostaglandin analogue PGF2a. was tested in immediate post-operative 
cataract extraction eyes. Seventy-two eyes undergoing endocapsular cataract extraction 
with capsular bag intraocular lens implantation using viscoelastic substance were randomly 
assigned into two groups. Thirty-six eyes in latanoprost group received 0.005o/o latanoprost 
eye drop at the end of the operative procedure while another thirty-six eyes in control group 
received a topical drop of placebo ( tetrahydrozoline hydrochloride) similarly. In all other 
respects the eyes were treated identically. Intraocular pressure (lOP) was measured pre-
operatively and at 3, 6, 9 and 24 hours post-operatively. 
Pre-operatively the mean intraocular pressure was 12.31 ± 2.11 mmHg in the latanoprost 
group and 12.72 ± 2.49 mmHg in the control group. The mean lOP post-operatively was 
persistently higher than the pre-operative levels in both groups. An initial rise in mean lOP 
was noted at 6 hours post-operatively (from 17.75 to 21.80 mmHg). Subsequently, the 
mean lOP drops with the lowest post-operative lOP was noted at 24 hours post-operatively. 
Similar pattern of lOP changes were also seen in latanoprost group, however the mean lOP 
levels were always lower than lOP level in control group (from 15.94 to 19.11 mmHg). The 
highest mean post-operative lOP was 21.80 ± 7.32 mmHg. recorded in the control group at 
6 hours post-operatively. The differences in the mean pressures in the two groups at 
corresponding times were not statistically significant (J> > 0.05). 
xi 
In conclusion, a single dose of 0.005% latanoprost given at the end of surgery did not 
produce a significant lOP-lowering effect when compared with a control group in the first 
24 hour period post-operatively. 
xii 
~~---------------------
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I 
1. INTRODUCTION 
INTRODUCTION 
The acute rise in intraocular pressure (lOP) during the first twenty-four hours after 
cataract extraction has been documented for over 30 years (Gormaz, 1962, Rich et. al, 
1974). Most eyes are tolerable to this transient raise in lOP without any clinically 
significant functional change or long term deleterious effect. However, the risk of 
permanently blinding ocular complication, particularly anterior ischaemic optic 
neuropathy do exist (Beri et. al, 1987, Hayreh, 1980). It becomes more critical to 
individuals with pre-existing vascular insufficiency (Hayreh, 1980). 
Awareness of such complications has led to the prophylactic use of various 
pharmacological agents, including timolol, acetazolamide and intracameral 
acetylcholine. Timolol or carbonic anhydrase inhibitors were usually used post-
operatively to control the lOP. Although effective, inhibition of aqueous production 
may disrupts the normal circulation of ions, glucose, enzymes, and metabolites 
necessary for proper homeostasis of the corneal endothelium and trabecular meshwork 
(Sears, 1981, Becker, 1995). Beside that, their side effects frequently constraint its 
routine use. An ideal drug to be used to prevent lOP spike should have minimal ocular 
and systemic adverse effects, with rapid onset of action for protection in the immediate 
post-operative period and prolong action to cover 24 hour postoperative ocular 
hypertensive period. 
The rise in lOP during the postoperative period may be caused by obstruction of the 
trabecular outflow by inflammatory material or retained viscoelastic material. The latter 
has been shown to remain trapped in the trabecular meshwork even after its aspiration 
from the anterior chamber following intraocular lens implantation. It is not known 
whether obstruction of the trabecular pathway immediately after surgery also extends to 
the uveoscleral pathway. It is also not known whether by pharmacologically enhancing 
uveoscleral outflow would significantly and safely decrease the postoperative lOP. 
A new group of ocular hypotensive agent, the prostaglandin F2a (PGF 2a) analogue 
(latanoprost), marketed as Xalatan as the trade name, has been extensively studied on 
human volunteers, ocular hypertensives and primary open angle glaucoma (POAG) 
patients. We performed a controlled double blind clinical trial, to determine the effect of 
Latanoprost on intraocular pressure after cataract extraction. Latanoprost was 
specifically chosen because of its different mechanism in action compared to the timolol 
and carbonic anhydrase inhibitors, by increasing the uveoscleral outflow. The 
recommended therapy of one drop per day will avoid disturbing patient post-operatively 
for at least 24 hours. 
2 
1.1 AIM OF STUDY 
To determine the effect of Iatanoprost 0.005% (prostaglandin F2a analogue) on 
intraocular pressure during the frrst 24 hours post-operative period after cataract 
extraction. 
3 
2. BACKGROUND INFORMATION 
BACKGROUND INFORMATION. 
2.1 HISTORY 
2.1.1 The effect of cataract extraction on the intraocular pressure 
Cataract extraction has been documented to change the intraocular pressure (lOP) post-
operatively since. mid fifties, before the widespread use of modem microsurgical 
techniques. Earlier studies by Hilding (1955) reported a reduction in lOP after 
intracapsular cataract extraction. The lOP measurements were made only after 12th post-
operative days, and he presumed that the lOP were zero or close to it in the immediate 
post-operative period. The cause of the hypotony was postulated to be due to trauma on 
ciliary body, filtration angle, or iris, individually or in combination, following surgical 
manipulation. The traction and tearing of the zonule cause oedema or hemorrhage or 
both of the ciliary body, disturbing the electrical potentials between the stroma and the 
epithelium, producing a reduction in aqueous production. The general congestion might 
enhance the rate of outflow. Those with collapse anterior chamber post-operatively were 
assumed to have wound leak. 
The first reported ocular hypertension following cataract extraction was made by 
Gormaz in 1962. He noted a rise in lOP one-day after intracapsular cataract extraction 
without the use of alpha-chemotrypsin. His fmding was supported by Kirsch in 1964, 
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which described an accentuation of this pressure rise associated with the use of alpha-
chemotrypsin during intracapsular cataract extraction. 
In mid sixties, operating microscope became popular among the ophthalmic surgeons. 
Delicate surgical instruments, fine needles and sutures materials came in together with 
the development of microsurgical techniques. About the same time, modem 
microsurgical extracapsular cataract extraction then was introduced. Foil owing this, 
there was revived interest in the posterior chamber lens implantation. 
With development of microsurgical technique, the multiple suturing method now 
becomes one of the factors for the cause of lOP alteration postoperatively. Rich (1968) 
demonstrated an accentuation of postoperative pressure rise 24 hours after intracapsular 
cataract extraction, with the use of multiple suture technique. He suggested that this 
resulted from a reduction in wound leakage. There were however questions raised as to 
the lOP rise was due to surgical interference with the trabecular' meshwork and the 
outflow channels. To answer those questions, Rich (1969) in his furthering studies 
demonstrated that there was a significant rise of lOP even when the section was purely 
corneal, with no surgical trauma to the trabecular meshwork. He suggested that a likely 
cause of the hypertension was the breakdown of the blood aqueous barrier during the 
immediate postoperative phase. The changes in the secondary aqueous for the purpose 
of healing contained higher protein, fibrin and cells, and were thicker in consistency, 
making it difficult to drain out of a watertight wound even through undamaged 
chalUlels. 
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Rich and co-worker first described the kinetics of the early postoperative lOP surge in 
197 4. They found out that lOP reached an average peak of 39.3 mm Hg at a mean time 
of 6.8 hours after surgery. The lOP then decreased to an average of 23.1 mm Hg. after 
24 hours post-operation. Similar result has been obtained from the latest study in 1988 
by Gross et. al. They noted an acute increase in lOP started as early as 3 hours 
postoperatively and the pressure then decreased to preoperative level after 24 hours 
postoperation. Mean intraocular pressure after two to three hours postoperatively was 
8.9 mm Hg. greater than the preoperative levels. 
The exact mechanism of this rise in lOP is still unknown. Galin and co-workers in 1978 
found a greater increase in lOP in the first 24 hours to those who underwent 
intracapsular cataract extraction with intraocular lens implant than the comparable 
control without implant. Those with extracapsular cataract extraction and lens implant 
had even higher rise of lOP in the frrst 24 hours (Galin, Lin and Obstbaum, 1978) The 
manipulative, mechanical and even chemical causes of inflammation were higher with 
more complicated procedures. It was concluded that all things being equal, any increase 
in inflammation led to an increase in lOP through increased outflow resistance. Gross 
et. al. ( 1988) suggested the increase in lOP may caused either from mechanical 
obstruction of the trabecular meshwork by zonular fragments, debris, or deformation of 
the angle structures beside the inflammation itself (Gross et. al, 1988 ). 
However, with introduction of viscoelatic substances in the late seventies, Binkhorst 
(1980) was first to note that the post-operative rise in lOP might be accentuated by the 
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using of sodium hyaluronate into the anterior chamber. He reported marked elevation of 
lOP during the first 24 to 72 hours after operation in a group undergone extracapsular 
cataract extraction with healon, compared to the group which undergone similar 
operation without healon. The maximum lOP measurement was at day one post-
operation. Other previous studies also reported similar results of raised lOP post-
operatively in cataract extraction using sodium hyaluronate, however most of them did 
not focus on the lOP in the frrst 24 hours post-operation (Grosset. al, 1988, Naesser et. 
al, 1986, Passo et. al, 1985). Barron and associates (1985) were the first to document the 
increase in pressure that occurred within the initial 24-hour period after cataract surgery 
using healon. Raised lOP was found at 3 hours post-operatively and persisted above the 
pre-operative level till one-week post-operative period. The maximum mean pressure 
was 28.8 mmHg ± 11.9 ( + 11.3 mmHg ± 11.0 difference from the pre-operative 
measurement) at 6 hours after surgery. Passo and his co-worker (1985), on the other 
hand noted the maximum lOP at 16 hours post-operatively with the mean difference of 
+16.7 mmHg ±1.1 from the pre-operative level. The lOP only normalized to the pre-
operative level at 72 hour post-operatively. 
Healonid allows complex surgical manipulation in the anterior chamber, improves 
visibility while protecting the corneal endothelium and enclose tissues from the trauma 
of surgical instrumentation. The exact mechanism of post-operative increase in lOP 
after using healonid is not well Wlderstood but was thought to be secondary to a 
decrease in outflow facility (Lazenby et. al. 1981, Percival, 1982). Since healonid is a 
high viscosity substance, it has a great difficulty in leaving the anterior chamber through 
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the trabecular meshwork and in the mean time causing outflow obstruction. They exit 
from the eye via outflow channels without being metabolized. The viscosity has to be 
reduced with aqueous before this hydrophilic substance may run through the trabecular 
meshwork (Percival 1982). Post-operatively remaining viscoelastic seems to 
depolymerise and leave the anterior chamber (AC) during the period not exceeding 48-
72 hours (Pape & Balazs, 1980). In an experimental study in human cadaver eyes, the 
instillation of sodium hyaluronate caused a 65% decrease in outflow facility (Berson et. 
al,1983). The amount of lOP rise allied directly with the amount of sodium hyaluronate 
remained in the anterior chamber (Barron et. al. 1985). Due to this reason, the practice 
of diluting or removing the viscoelastic substance at the end of the surgery in attempt to 
prevent postoperative increase in lOP has been recommended (Lazenby & Brooker, 
1981). 
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2.1.2 Complications of post-operative ocular hypertension 
Among the complications of an acute rise in lOP following routine cataract surgery is 
post cataract extraction anterior ischaemic optic neuropathy (PCE- AION). It is the 
most serious blinding ocular complication, with poor prognosis for recovery of the 
vision. It is caused by the acute high rise in lOP during the immediate post-operative 
period in eyes with vulnerable optic nerve head circulation. Thus, in susceptible 
persons, i.e. with arteriosclerosis, atherosclerosis, and cardiovascular disorders, and to 
eyes with poor circulation in the optic nerve head, a transient ocular hypertension can 
easily compromise a circulation in the optic nerve and produce PCE-AION. There is a 
high risk in the development of PCE-AION in the second eye patients with PCE-AION 
in the frrst eye. (Hyreh, 1974, 1980, Beri et. al. 1987). 
Increased lOP may also be associated with post-operative pain, corneal edema, and loss 
of visual field in patients with pre-existing glaucoma. 
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2.1.3 Agents used previously in preventing post-operative ocular hypertension. 
A number of agents have been tried in attempt to reduce the possible rise in lOP 
following cataract extraction. It started with Rich in 1969 where he demonstrated that 
administering 500mg. of acetazolamide (carbonic anhydrase inhibitor ) intramuscularly 
at the end of the operation, followed by 250mg. orally every six hours for 24 hours, did 
not completely succeed in preventing postoperative ocular hypertension. It did however 
produce a statistically significant lowering of the hypertensive response in 24 hours. 
Acetazolamide decrease the intraocular pressure by declining the rate of aqueous 
secretion. 
In 1977, Rich again demonstrated a favourable response using prostaglandin inhibitors. 
Since prostaglandin was implicated as a contributor factor in the postoperative ocular 
hypertensive response, by inhibiting its synthesis, he proved that he could reduce this 
response. By dividing the patients into three groups, he used oral indomethacin 25mg. 
every 6 hours for 48 hours preoperatively in the first group, oral acetylsalicylic acid 
900mg. preoperatively in the second group, and a group of patients as a control 
measurement. He found that those drugs caused a significant reduction in the IOP rise 6 
hours postoperatively but did not abolish it. The control group showed lOP rise about 3 
times the preoperative level at 6 hours postoperatively. However, because of their 
irritant effect upon the gastric mucosa, it was not recommended for those with 
gastrointestinal disease. 
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Timolol has been investigated as a prophylaxis for postoperative raised in lOP by 
Obstbaum and Galin in 1979. They showed that prophylactic timolol 0.25% (a beta-
adrenergic block which decrease aqueous secretion) instill topically at the completion of 
intracapsular cataract extraction without the use of alpha-chymotrypsin but with iris 
supported lens implant, reduced the postoperative lOP measured at 24 hours. This 
effect, in the absence of pupillary changes, made timolol advantageous in iris supported 
lens implanted eyes, where dilatation or undue constriction, may be dangerous. 
However, different story occurs in the case of extracapsular cataract extraction using 
sodium hyaluronate. Ruiz and co-workers (1987) in their study on timolol 0.5%, 
pilocarpine 4% eyedrop and pilocarpine 4% gel, demonstrated that timolol 0.5% 
instilled topically at the completion of extracapsular cataract extraction with the use of 
sodium hyaluronate and posterior chamber lens implant, failed to produce a statistically 
significant effect on the intraocular pressure 24 hours postoperatively. Similarly, the use 
of pilocarpine 4% eyedrop, showed minimal benefit, though, pilocarpine 4% gel 
significantly reduced the mean intraocular pressure 24 hours post-operatively. However, 
all groups showed a significant increase in lOP when compared with baseline values 
(P<O.OOl). 
Acetylcholine, a cholinergic agent has been used for many years as an adjunct in 
cataract extraction for its miotic effect. However, little attention had been paid to its 
effect on lOP. As with other cholinergic agents such as carbamylcholine (carbachol), 
acetylcholine have a direct effect on the ciliary muscle and were expected to increase 
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outflow facility through effects on the trabecular meshwork.. Hollands, Drance and 
Schulzer (1987) showed 0.75ml of intracameral acetycholine 1% at the completion of 
extracapsular cataract extraction and posterior chamber intraocular lens implant without 
the use of viscoelastic substance have no effect beyond six hours from the time of 
surgery. Acetylcholine was rapidly broken down by the action of acetylcholinesterase 
that accounted for the lack of sustained effect on the lOP. In a similar study (Hollan, 
Drance and Schulzer, 1987) they examined the use of 0.4ml intracameral 0.01% 
carbachol and found that the lOP was significantly lower for 24 hours post-operatively. 
This is because of the carbachol was resistant to enzymatic hydrolysis and therefore 
active for a longer period. 
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2.2 LATANOPROST 
2.2.1 Chemical structure of Latanoprost (PhXA41) 
OH 
PhXA41 
Latanoprost 
2.2.2 Pharmacological properties 
Latanoprost ( PhXA41 ; Xalatan™ ), one of the PGF2a. analogue, is a drug from a new 
group of ocular hypotensive agents, the prostaglandin (PGs ). It is a selective prostanoid 
FP receptor agonist which reduce the lOP by increasing the outflow of aqueous humor 
through the uveaoscleral outflow.(Lindsey et. al. 1997). Several mechanisms have been 
proposed to explain the increased in uveoscleral outflow on the basis effect of 
latanoprost on the ciliary muscle. One of the hypothesis is that the PGF2a. could induce 
ciliary smooth muscle cells to degrade adjacent extracellular matrix (ECM) in the 
spaces between ciliary smooth muscle fibers, thereby reducing the hydraulic resistance 
around the fibers. This will facilitate aqueous flow through the muscle (Lindsey et. al. 
1997). 
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Although there is some increase in outflow facility through conventional trabecular 
meshwork by the Iatanoprost, it is not sufficient enough to account for the observed lOP 
reduction (Kerstetter et. al. 1988). Besides, unlike few other ocular hypotensive agents, 
it did not reduce the aqueous humor production (Kerstetter et. al. 1988, Higginbotham, 
1996). Therefore it did not jeopardize the nutritional safety margin of avascular tissues 
in the anterior segment structures that depend on aqueous humor flow. This is 
particularly important especially to the trabecular meshwork where reduce aqueous 
humour production has potential in contributing to the deterioration of conventional 
outflow channels.(Becker, 1995) 
Latanoprost has not been found to have any effect on the blood-aqueous barrier. It has 
no negligible effects on the intraocular blood circulation when used in clinical dose and 
studied on monkeys. However, in the eyes with glaucoma and its related condition, 
Miyake and his co-worker (1999) showed that latanoprost therapy was noted to enhance 
disruption of the blood-aqueous barrier and increase the incidence of angiographic 
cystoid macular oedema (CMO) formation in early postoperative pseudophakias. In 
their study, the latanoprost was given for five days (two days before and three days after 
the operation), compared to our study which the drug was given for only one dose. 
Miyake et. al. also showed the administration of nonsteroidal eyedrop such as 
diclofenac seems to prevent this adverse effect oflatanoprost therapy. 
Latanoprost in clinical doses has not been found to have any significant 
pharmacological effects on the cardiovascular or respiratory system. 
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2.2.3 Pharmacokinetic properties 
Latanoprost is an isopropyl ester pro-drug that per se is inactive but after hydrolysis to 
the acid of latanoprost becomes biologically active. The pro-drug is well absorbed 
through the cornea and all drugs that enter the aqueous humour are hydrolysed during 
the passage through the cornea. The reduction of the lOP in man starts about 3 to 4 
hours after administration and maximum effect is reached after 8 to 12 hours. Pressure 
reduction is maintained for at least 24 hours, therefore recommended therapy is one 
drop once daily (Diestelhorst et. al., 1997). 
In three-center randomized, double-masked, one month study of twice-daily treatment 
with placebo or 0.0035%, 0.006% and 0.0115% latanoprost, the mean lOP reduction 
was between 31% and 3 8%, with only one week dose response relationship, suggesting 
that the low concentrations were close to the mean ocular hypotensive dose response 
curve for latanoprost (Aim et. al., 1993). The commercially available preparation of 
latanoprost are 0.005% and each ml. of latanoprost 0.005% contains 50 meg latanoprost 
and benzalkonium chloride 0.2 mg/ml. For each drop of latanoprost contains 
approximately 1.5 J.Lg latanoprost. 
After topical application on monkeys, latanoprost is distributed primarily in the anterior 
segment, the conjunctiva, and the eyelids. There is practically no metabolism of the acid 
of latanoprost in the eye. The main metabolism occurs in the liver. The half life in 
plasma is I7 minutes in man. The main metabolites, the I ,2-dinor and I ,2,3,4-tetranor 
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metabolites, exert no or only weak biological activity in animal studies and are excreted 
primarily in the urine. 
2.2.4 Side effects 
The side effects of latanoprost are mainly ocular with no systemic side effect reported 
before. Ocular side effects mostly occur in an eye with prolonged used of latanoprost 
and include the following; 
a) increased pigmentation of the iris 
b) darkening, thickening and lengthening of the eyelashes. 
c) Darkening of the palpebral skin of the lids (very rarely been noted) 
d) Slight foreign body sensation 
e) Mild conjunctival hyperaemia (noted in about 10% of patients) and moderate 
hyperaemia (noted in about 1% of patients) 
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3. MATERIALS AND JVIETHODS 
MATERIAL AND METHODS. 
3.1 STUDY DESIGN 
This is a randomized, double-masked clinical trial which include patients undergone 
uncomplicated extracapsular cataract extraction with posterior chamber intraocular lens 
implantation. 
3.2 SAMPLING 
All consecutive patients, who were admitted to the hospital Universiti Sains Malaysia, 
Kubang Kerian, Kelantan for extracapsular cataract extraction with intraocular lens 
implantation under local anaesthesia between May 1999 and September 2000, who met 
the selection criteria were taken for the study. 
They were randomly assigned into two groups. The latanoprost group (group A) 
consisted of patients who received a drop of guttae latanoprost 0.005% at the end of the 
surgical procedure. The control group (group B) consisted of patients who received a 
drop of guttae optizoline {Tetrahydrozoline hydrochloride) at the end of the surgical 
procedure. 
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3 .2.1 Sample size 
A minimum of 54 patients was required for this study based on calculation using 
Pocok's formula with the power of the study of90%. 
3.3 PATIENT SELECTION 
Patients were selected according to the following criteria; 
a) Age between 40 and 80 year old. 
b) Pre-operative intraocular pressure below 22 mmHg in either eye. 
c) Axial length of the eyeball between 22 and 26 mm. 
d) No history of glaucoma, uveitis, retinal detachment and intraocular surgery 
before. 
e) No history of long-term use of ocular medications. 
f) No history of presently being on carbonic anhydrase inhibitors, diuretics, 
hyperosmotic agents, corticosteroids or anti-inflammatory agents. 
g) No evidence of glaucomatous cupping of the optic disc of either eye (when 
visible) 
h) No clinically significant visible ocular abnormalities other than cataract. 
i) No contraindication to the use of posterior chamber intraocular lens. 
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3.4 CRITERIA FOR EXCLUSION 
Patients were excluded from the study after selection if the following events occurred; 
a) A posterior chamber intraocular lens could not be inserted. 
b) Heal on had to be retained in the anterior chamber. 
c) Carbachol had to be used for what ever reason. 
d) Any complications intraoperatively causing ruptured posterior capsule. 
3.5 CRITERIA FOR DIS-CONTINUING FROM THE STUDY 
Patients were discontinued from the study if the intraocular pressure was found to be 
more than 30mmHg during any post-operative measurement. The patient will be treated 
accordingly and the subsequent measurements would not be a true reflection of the 
pattern of post-operative intraocular pressure anymore. The intraocular pressure of more 
than 30mmHg were chosen since it is known to cause ocular complications. 
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3.6 l\1INI1\1ISING ERROR 
Attempts in minimize the sampling and non-sampling errors were made by the 
following means; 
a) Randomized selection of patients into two groups. 
b) Masked, double blind study technique. 
c) The intra-ocular lens (polymethylmethacrylate by pharmacia, model 808C) 
was inserted in the capsular bag (posterior chamber) in all patients. 
d) The viscoelastic substance {Healon GV) used, were same in all patients. 
e) All surgeries were performed by two identified surgeon using the same 
preoperative and intraoperative procedures in all patients, who was masked 
to each patient's treatment group. 
f) All intraocular pressure measurements were taken by the same individual, 
who also was masked, to each patient's treatment group. 
g) Only the surgical assistant was aware of the drug given in each case.. The 
data regarding the patient and the treatment given was kept in a separate file 
that was kept by the surgical assistant. 
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3.6 PRE-OPERATNE EVALUATION 
3.6.1 History 
A careful history was taken in all patients. This included present and past history of 
ocular problems, ocular surgery and ocular medication. 
3.6.2 Ocular examination 
Ocular examination started with using slit lamp biomicroscopy was done with special 
emphasis on the evidence of past or present uveitis, anterior chamber depth, rubeosis, 
pupil abnormalities and degree of lens opacities. In a case where the anterior chamber 
looks shallow, a gonioscopic examination was done to exclude angle abnormality and 
narrow angles. 
Intraocular pressure was measured pre-operatively in the both eyes using the same 
Goldman applanation tonometer. Measurements were made with the tonometer prism 
aligned horizontally, without any pupillary dilatating medication. All measurements 
were made between 10 am and I pm, one day prior to surgery. 
Ophthalmoscopic examination after pupillary dilatation was done for the both eyes after 
intraocular pressure measurement (the morning, a day before the operation). The optic 
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disc and cup-disc ratios were noted. If the cataract was too dense to visualize the 
fundus, B-scan was done to exclude posterior segment abnormalities. 
3 .6.3 General examination 
General and systemic examination was done for all cases to determine general fitness 
for the operation. 
3 .6.4 Laboratory investigations 
Routine laboratory investigations were done a week prior to surgery. They consisted of 
blood sugar profile and electrocardiogram to determine the general fitness of the patient 
for the operation. 
3.6.5 Demographic data and consent 
For the patient who fulfill the criteria for selection, the demographic data were taken 
and recorded in form A (appendix n. The data recorded includes; 
a) Age of the patient 
b) Sex 
c) Eye selected: OD/OS 
d) Axial length of the eye ball 
e) Type of cataract 
t) Pre- operative intraocular pressure. 
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Consent was taken from the patient after the explaination regarding the study given to 
the patient. (Appendix II). 
3.7 PRE-OPERATIVE MYDRIASIS AND :MEDICATION 
Pre-operative mydrasis was achieved by using 1% tropicamide and 2.5% phenylephrine 
instilled three times at 15 minutes interval approximately an hour before surgery. 
Premedication of intramuscular Promethazine hydrochloride (phenergan) 25mg and 
Pethidine lmg/kg were given about one hour prior to surgery. 
3.8 ANAESTHESIA 
All cases were done under local anaesthesia using retrobulbar block. The local 
anaesthesia was given 15 minutes prior to surgery using 3 ml. of 50/50 mixture of 2% 
lignocaine and 0.5% bupivacaine. 
A Van Lint block using 5ml. of the same mixture was also given after the retrobulbar 
injection. 
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3.9 PRE-OPERATIVE INTRAOCULAR PRESSURE REDUCTION 
This was achieved using digital massage over the globe in all cases for 5 minutes soon 
after the retrobulbar injection was given. A constant pressure of Smm Hg was then 
applied to the globe using Honan balloon for approximately 10 minutes. 
3.10 SURGICAL TECHNIQUE 
A standard manual cataract extraction was performed on all patients. The sequences of 
the operation were as follows; 
a) Barraquer's eye speculum was used to keep the eyelids open. 
b) A superior rectus bridle suture was applied. 
c) F omix based conjunctival incisions was made followed by posterior or limbal 
corneal incision. 
d) Heaton GV (figure 1) injected into the anterior chamber to deepen the chamber and 
protect the endothelium 
e) Anterior endocapsulotomy performed. 
f) The nucleus expressed, and the cortical remnant was aspirated with the simco 
irrigation-aspiration cannula. 
g) Heal on GV again injected into the bag and anterior chamber. 
h) Intraocular lens (figure 2) inserted into the capsular bag. 
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